Literature DB >> 19465894

Diagnosis: Novel molecular signatures for adrenocortical carcinoma.

Matthias J Betz, Felix Beuschlein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465894     DOI: 10.1038/nrendo.2009.93

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  6 in total

1.  Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.

Authors:  Thomas J Giordano; Rork Kuick; Tobias Else; Paul G Gauger; Michelle Vinco; Juliane Bauersfeld; Donita Sanders; Dafydd G Thomas; Gerard Doherty; Gary Hammer
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

2.  Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.

Authors:  Aurélien de Reyniès; Guillaume Assié; David S Rickman; Frédérique Tissier; Lionel Groussin; Fernande René-Corail; Bertrand Dousset; Xavier Bertagna; Eric Clauser; Jérôme Bertherat
Journal:  J Clin Oncol       Date:  2009-01-12       Impact factor: 44.544

Review 3.  Pathological and molecular features of adrenocortical carcinoma: an update.

Authors:  M Volante; C Buttigliero; E Greco; A Berruti; M Papotti
Journal:  J Clin Pathol       Date:  2008-04-22       Impact factor: 3.411

Review 4.  Clinical review: Adrenocortical carcinoma: clinical update.

Authors:  Bruno Allolio; Martin Fassnacht
Journal:  J Clin Endocrinol Metab       Date:  2006-03-21       Impact factor: 5.958

5.  Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy.

Authors:  Cristina L Ronchi; Silviu Sbiera; Luitgard Kraus; Sebastian Wortmann; Sarah Johanssen; Patrick Adam; Holger S Willenberg; Stefanie Hahner; Bruno Allolio; Martin Fassnacht
Journal:  Endocr Relat Cancer       Date:  2009-02-24       Impact factor: 5.678

6.  Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.

Authors:  Martin Fassnacht; Sarah Johanssen; Marcus Quinkler; Peter Bucsky; Holger S Willenberg; Felix Beuschlein; Massimo Terzolo; Hans-Helge Mueller; Stefanie Hahner; Bruno Allolio
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860

  6 in total
  3 in total

Review 1.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

2.  HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer.

Authors:  Ming-Ling Chang; Shi-Ming Lin; Chau-Ting Yeh
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

3.  Hepatoma upregulated protein expression is involved in the pathogenesis of human breast carcinogenesis.

Authors:  Jin Chen; Qiu-Jun Liu; DA Wang; Xian-Yao Zhou; Ding Xiong; Hong-Jiang Li; Chang-Long Li
Journal:  Oncol Lett       Date:  2014-10-13       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.